8-Propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one: A new coumarin with monoamine oxidase B inhibitory activity and possible anti-parkinsonian effects

• Autores principales: María del Pilar Olaya (Autor), Nadezdha Esperanza Vergel (Autor), Jose Luis López (Autor), Dolores Viña (Autor), Mario Francisco Guerrero (Autor)
• Formato: Libro
• Publicado: Universidade de São Paulo, 2020-03-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Parkinson's disease is a common neurodegenerative disorder. In this study, the monoamine oxidase inhibitory activity and potential anti-parkinsonian effects of 8-propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one (FCS303), a new synthetic coumarin, were evaluated. To do this, we used the reserpine mode...